Johnson & Johnson Innovative Medicine is recruiting for a Group Medical Director, New Products, Solid Tumor Oncology, located in Horsham, PA.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world's most pressing healthcare challenges.

• The Group Medical Director (GMD), New Products will have medical oversight of multiple projects and/or products for solid tumor pipeline assets, reporting to the Head, New Products in Solid Tumor Medical Affairs.
• The GMD New Products will develop the medical strategy for assigned projects / products with a goal to address medical and scientific issues. The medical strategy will be aligned with Medical Affairs (MA) leadership and the Integrated Strategy and Scientific Strategy teams.
• The GMD New Products will have higher degree of autonomy in working with MA leadership to devise strategies addressing crucial gaps via critical relationships across Medical Affairs, Global Medical Affairs, R&D, V&E, Commercial and others. He/she will lead and effectively partner with Alliance partner (if applicable) on those activities.
• Contribute to the Integrated Evidence Generation Plan and the strategic publication plan for pipeline products.
• Develops and aligns Advisory Board strategy, executes Advisory Boards and maintains relationships with external investigators, opinion leaders and patient advocacy groups.

• MD (or equivalent), PharmD, PhD required. Strongly preferred MD (Medical Oncologist preferred).
• Board certification in Oncology or related field is preferred.
• Solid Tumor experience is required. Knowledge of lung, colorectal, head and neck cancers is preferred.
• A minimum of five years of experience in a strategy-setting role with at least two years in the pharmaceutical industry or equivalent experience is preferred.
• Experience in developing or launching a new pharmaceutical/biologic product is preferred.
• Experience in pharmaceutical trial design and conduct (Phases II-IV) within the pharmaceutical industry, CRO or academia is preferred.
• Excellent written, oral and presentation skills are required.
• Strong organizational skills are a must.
• A demonstrated ability to work in a matrix type environment with interaction with cross-functional teams is required.
• This position requires up to 25% annual travel (domestic and international).